ingineeon GmbH

ingineeon GmbH is dedicated to revolutionizing patient care through breakthrough medical innovations. Specializing in the development of advanced cytokine-based immunotherapeutics, ingineeon GmbH is focused on creating first-in-class biologics to address critical needs in infectious diseases, inflammatory diseases, and oncology. The primary address of ingineeon GmbH is in Munich, DE, positioning the company at the heart of European biotech innovation.

ingineeon GmbH’s mission is driven by a commitment to translate cutting-edge research into tangible medical solutions. With a robust pipeline of pioneering therapeutics, ingineeon GmbH is strategically positioned for rapid growth and clinical advancement. As a spin-off from the Technical University of Munich, ingineeon GmbH leverages academic excellence and entrepreneurial spirit to achieve its ambitious goals.

With a focus on innovation and clinical impact, ingineeon GmbH is poised to become a leader in the biotechnology sector. We invite the manager of ingineeon GmbH to take advantage of our platform to create a customized and exclusive company showcase and product listing, further amplifying your market presence and commercial development.